Tag: Moderna

FDA Approves Moderna’s Second Booster
March 29, 2022 Off

FDA Approves Moderna’s Second Booster

By Author

Moderna, Inc. (NASDAQ:MRNA) has received approval from the U.S. Food and Drug Administration (FDA) for its amendment to the emergency use authorization (EUA) to allow for a second booster dose of its COVID-19 vaccine (mRNA-1273) at the 50 µg dose level in adults 50 years of age and older who have received an initial booster of any of the authorized or approved COVID-19 vaccines and adults 18 years of age and older with certain kinds of immunocompromise.

Moderna asks FDA’s approval for the 4th Dose Covid-19 Vaccine
March 18, 2022 Off

Moderna asks FDA’s approval for the 4th Dose Covid-19 Vaccine

By Dino Mustafić

Moderna has submitted a request to the U.S. Food and Drug Administration (FDA) for an amendment to the emergency use authorization (EUA) to allow for a fourth dose of its COVID-19 vaccine (mRNA-1273) in adults 18 years of age and older who have received an initial booster of any of the authorized or approved COVID-19 vaccines.

Moderna’s Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains
December 10, 2021 Off

Moderna’s Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains

By Dino Mustafić

Moderna today announced the first positive interim data from the Phase 1 study of the Company’s quadrivalent seasonal flu vaccine candidate, mRNA-1010, as it successfully boosted hemagglutination inhibition (HAI) assay geometric mean titers against all strains 29 days after vaccination at all doses tested in both younger and older adults.

Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia
June 14, 2021 Off

Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia

By BusinessWire

-Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceuticals company, today announced an agreement to commercialize the Moderna COVID-19 Vaccine and future variant-specific booster candidates in Saudi Arabia.

Moderna confirms talking with the US on 100M doses of Cov-19 vaccine
January 28, 2021 Off

Moderna confirms talking with the US on 100M doses of Cov-19 vaccine

By Dino Mustafić

After the US president’s Biden said the US Federal government would buy 100 million doses of the COVID-19 vaccine from Moderna and another 100 million from Pfizer, Moderna today confirmed that it is in discussion with the U.S. government to purchase an additional 100 million doses of the Moderna COVID-19 Vaccine for delivery in the third quarter of 2021.

Moderna’s vaccine coming to India
January 25, 2021 Off

Moderna’s vaccine coming to India

By Dino Mustafić

Reuters news agency referred to the Economic Times as saying Monday that Tata Group’s healthcare venture has reportedly started the first discussions with Moderna Inc for a partnership to launch its COVID-19 vaccine in India.